A

Aligos Therapeutics
D

ALGS

5.31000
USD
0.09
(1.72%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
280
الربح لكل سهم
-7
العائد الربحي
-
P/E
-1
حجم السوق
33,158,603

العنوان: Aligos Therapeutics Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.